Advertisement

Hepatotoxicity Associated with Cocaine Abuse

  • David H. Van Thiel
  • Joshua A. Perper
Part of the Recent Developments in Alcoholism book series (RDIA, volume 10)

Abstract

The mechanisms evaluated in animals as being responsible for cocaine associated hepatotoxicity are presented. The importance of the P-450 enzyme system in cocaine associated hepatotoxicity is emphasized. Moreover, the putative critical role of free radicals in such injury is discussed. Finally, the growing literature on clinical cases of cocaine hepatotoxicity is reviewed.

Keywords

Covalent Binding Cocaine Abuse Cocaine User Benzoyl eCgOnine Acute Cocaine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Abelson HI, Miller JD: A decade of trends in cocaine use in the household population. Natl Inst Drug Abuse Res Morwgr 61:35–49, 1985.Google Scholar
  2. 2.
    Fishburn PM: National Survey on Drug Abuse, Main Findings 1979, DHHS publication no. ADM 80-976. Rockville, MD, NIDA, 1980.Google Scholar
  3. 3.
    Crebler LL, Mark H: Medical complications of cocaine abuse. N Engl J Med 315:1495–1500, 1986.CrossRefGoogle Scholar
  4. 4.
    Marks V, Chappie PAL: Hepatic dysfunction in heroin and cocaine users. Br J Addict 62:189–195, 1967.CrossRefGoogle Scholar
  5. 5.
    Ehrlich P: Studies in der cocain reihe. Dtsch Med Wochenschr 16:717–719, 1890.CrossRefGoogle Scholar
  6. 6.
    Shuster L, Quimby F, Bates A, Thompson ML: Liver damage from cocaine in mice. Life Sci 20:1035–1042, 1977.PubMedCrossRefGoogle Scholar
  7. 7.
    Thompson ML, Shuster L, Shaw K: Cocaine-induced hepatic necrosis in mice—the role of cocaine metabolism. Biochem Pharmacol 28:2389–2395, 1979.PubMedCrossRefGoogle Scholar
  8. 8.
    Freeman RW, Harbison RD: Hepatic periportal necrosis induced by chronic administration of cocaine. Biochem Pharmacol 30:777–783, 1981.PubMedCrossRefGoogle Scholar
  9. 9.
    Evans MA: Role of protein binding in cocaine-induced hepatic necrosis. J Pharmacol Exp Ther 224:73–79, 1983.PubMedGoogle Scholar
  10. 10.
    Kloss MW, Rosen GM, Rauckman EJ: Cocaine-mediated hepatotoxicity: a critical review. Biochem Pharmacol 33:169–173, 1984.PubMedCrossRefGoogle Scholar
  11. 11.
    Donnelly DA, Boyer CS, Peterson DR, Ross D: Cocaine-induced biochemical changes and cytotoxicity in hepatocytes isolated from both mice and rats. Chem-Biol Interact 67:95–104, 1988.PubMedCrossRefGoogle Scholar
  12. 12.
    Kanel GC, Cassidy W, Shuster L, Reynolds TB: Cocaine-induced liver cell injury: comparison of morphological features in man and in experimental models. Hepatology 11:646–651, 1990.PubMedCrossRefGoogle Scholar
  13. 13.
    Thompson ML, Shuster L, Casey E: Sex and strain differences in response to cocaine. Biochem Pharmacol 33:1299–1307, 1984.PubMedCrossRefGoogle Scholar
  14. 14.
    Smith AC, Freeman RW, Harbison RD: Ethanol enhancement of cocaine-induced hepatotoxicity. Biochem Pharmacol 30:453–458, 1981.PubMedCrossRefGoogle Scholar
  15. 15.
    Stewart DJ, Inaba T, Lucassen M, Kalow W: Cocaine metabolism: cocaine and norcocaine hydrolysis by liver and serum esterases. Clin Pharmacol Ther 25:464–468, 1979.PubMedGoogle Scholar
  16. 16.
    Charkoudian JC, Shuster L: Electrochemistry of norcocaine nitroxide and related compounds: implications for cocaine hepatotoxicity. Biochem Biophys Res Commun 130:1044–1051, 1985.PubMedCrossRefGoogle Scholar
  17. 17.
    Rauckman EJ, Rosen GM, Cavagnaro J: Norcocaine nitroxide: a potential hepatotoxic metabolite of cocaine. Mol Pharmacol 21:458–463, 1982.PubMedGoogle Scholar
  18. 18.
    Peterson FJ, Knodell RG, Lindemann NJ, Steele NM: Prevention of acetaminophen and cocaine hepatotoxicity in mice by cimetidine treatment. Gastroenterology 85:122–129, 1983.PubMedGoogle Scholar
  19. 19.
    James RC, Schiefer MA, Roberts SM, Harbison RD: Antagonism of cocaine-induced hepatotoxicity by the a adrenergic antagonists phentolamine and yohimbine. J Pharmacol Exp Ther 242:726–732, 1987.PubMedGoogle Scholar
  20. 20.
    Perino LE, Warren GH, Levine JS: Cocaine-induced hepatotoxicity in humans. Gastroenterology 93:176–180, 1987.PubMedGoogle Scholar
  21. 21.
    Wanless IR, Dore S, Gopinath N, Tan J, Cameron R, Heathcote EJ, Blendis LM, Levy G: Histopathology of cocaine hepatotoxicity. Report of four patients. Gastroenterology 98:497–501, 1990.PubMedGoogle Scholar
  22. 22.
    Silva MO, Roth D, Reddy KR, Fernandex JA, Albores-Saavedra J, Schiff ER: Hepatic dysfunction accompanying acute cocaine intoxication. J Hepatol 12:312–315, 1991.PubMedCrossRefGoogle Scholar
  23. 23.
    Comeer GM, Mittal MK, Donelson SS, Lee T-P: Cluster of fulminant hepatitis B in crack users. Am J Gastroenterol 86:331–334, 1991.Google Scholar
  24. 24.
    Kothur R, Marsh F, Posner G: Liver function tests in non-parenteral cocaine users. Arch Intern Med 151:1126–1128, 1991.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1992

Authors and Affiliations

  • David H. Van Thiel
    • 1
  • Joshua A. Perper
    • 2
  1. 1.Department of SurgeryUniversity of Pittsburgh School of MedicinePittsburghUSA
  2. 2.Allegheny County Coroner’s Office, Departments of Pathology and Epidemiology, School of Medicine and School of Public HealthUniversity of PittsburghPittsburghUSA

Personalised recommendations